Metastatic prostate cancer patients who received an investigational vaccine made from their own frozen immune cells lived 10 months longer than those not treated with it, according to data presented by researchers at the Kimmel Cancer Center at Jefferson.
Researchers have concluded a Phase II study of an investigational vaccine against group B Neisseria meningitidis, which shows promising results.
Insurance companies and employers are now required to provide consumers in the private health insurance market with tools to help improve and clarify the insurance policy selection process.
Researchers tested a third dose of the measles-mumps-rubella vaccine on students in an affected community in an effort to control the outbreak.
A meta-analysis showed IVIG was as effective as plasma exchange in reducing Guillain Barré syndrome disability scores, with no significant difference in adverse events.
The U.S. Department of Health and Human Services has a new program to help care for mental and behavioral illnesses.
The Department of Health and Human Services and the Department of Veterans Affairs have developed a demonstration of the standards to permit sensitive health information to be shared responsibly among providers using electronic health records, while abiding by confidentiality rules and guidelines.
The U.S. House of Representatives Energy and Commerce Committee has approved H.R. 1206, the Access to Professional Health Insurance Advisors Act, with a 26-14 vote.
The Immunoglobulin Nursing Society (IgNS) held its first national conference in Orlando, Fla., August 3 through 5.
Baxter International has received U.S. Food and Drug Administration approval for a 4,000 IU dosage of Advate (Antihemophilic Factor [Recombinant], Plasma/Albumin-Free Method).
Beginning in 2014, nearly six million U.S. citizens are expected to purchase health insurance or face an average tax penalty of $1,200, following a Supreme Court 5-4 decision this past summer that upheld the constitutionality of the Affordable Care Act.
The U.S. House of Representatives has introduced a bill that intends to clarify and shorten the U.S. Food and Drug Administration’s assessment process of mobile health apps.
